ClinicalTrials.gg
Status unknownNCT03313245Updated Oct 10, 2018

Diet Quality and Cognitive Control Function in Early Childhood: A Pilot Study

An observational study in Diet Habit and Cognitive Function, sponsored by University of Illinois at Urbana-Champaign. Status unknown at 1 site in United States. Open to participants aged 4 Years to 5 Years. Per ClinicalTrials.gov, last updated 2018-10-10.

Sponsored by University of Illinois at Urbana-Champaign · Observational

The sponsor has not verified this record recently (last verified Oct 2018), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
104
Ages
4 Years to 5 Years
Sex
All
01

Study summary

This study aims to study the relationship between diet and cognitive function among 4-5-year-olds.

Read the detailed description

Children's ability for optimal cognitive function is critical for their long-term capacity to learn and achieve scholastic success. However, there is a gap in the knowledge pertaining to the selection of appropriate cognitive tasks for studying relationships between diet and cognitive control, particularly among young children. Accordingly, this study aims to study the relationship between diet and cognitive function using a standardized neuropsychological assessment and a modified cognitive task battery.

02

Conditions studied

  • Diet Habit
  • Cognitive Function

Browse trials for

03

In context

Feeding Behavior

985 studies on the registry are indexed under Feeding Behavior; 178 are open to participants now.

This study's planned enrollment of 104 is below the median of 183 across 270 observational studies indexed under Feeding Behavior.

Browse Feeding Behavior studies →

Lead sponsor

University of Illinois at Urbana-Champaign is the lead sponsor of 191 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 5 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

4 and 5-year-olds

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Parental consent
  • Child Assent
  • 4 and 5 years of age
  • Absence of neurological disorders
  • Normal or corrected-to-normal vision

Exclusion criteria

Exclusion Criteria:

  • Younger than 4 and older than 5 years of age
  • Presence of neurological disorders
  • Uncorrected vision
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
104 participants (estimated)
Patient registry
No

Interventions

  • OtherNo Intervention/Observational Study

    No Intervention/Observational Study

06

What researchers measure

Primary outcomes

  1. Early Cognitive and Academic Development

    Woodcock Johnson IV eCAD

    Time frame: Once at laboratory visit

Secondary outcomes

  1. Attention

    2-stimulus Oddball task

    Time frame: Once at laboratory visit

  2. Cognitive Flexibility

    Hearts and Flowers Task

    Time frame: Once at laboratory visit

  3. Diet Quality

    Healthy Eating Index

    Time frame: 7-day average following first laboratory visit

07

Study locations

1 of 1 sites recruiting
  • Department of Kinesiology and Community Health
    Urbana, Illinois 61801, United States
    Recruiting
    • Naiman A Khan, PhD, RD · Contactnakhan2@illinois.edu · 217-300-2197
    • Naiman A Khan, PhD, RD · Principal investigator
    • Anne Walk, PhD · Sub investigator
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 10, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03313245
Collaborators
National Dairy Council
Responsible party
Naiman Khan (Assistant Professor, University of Illinois at Urbana-Champaign) — Principal investigator
First posted
Oct 18, 2017
Start date
Aug 1, 2016
Primary completion
Dec 31, 2018 (estimated)
Completion
Dec 31, 2018 (estimated)
Last update
Oct 10, 2018

Study contacts

Naiman A Khan, PhD, RD
Contact
nakhan2@illinois.edu
2173002197

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion